These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2858723)

  • 1. Reduced response of uraemic bleeding time to repeated doses of desmopressin.
    Canavese C; Salomone M; Pacitti A; Mangiarotti G; Calitri V
    Lancet; 1985 Apr; 1(8433):867-8. PubMed ID: 2858723
    [No Abstract]   [Full Text] [Related]  

  • 2. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia.
    Mannucci PM; Remuzzi G; Pusineri F; Lombardi R; Valsecchi C; Mecca G; Zimmerman TS
    N Engl J Med; 1983 Jan; 308(1):8-12. PubMed ID: 6401193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of 1-deamino-8-D-arginine vasopressin (DDAVP) on bleeding time in uremic patients].
    Alarcón F; Mezzano D; Vial S; Pereira J
    Rev Med Chil; 1985 Aug; 113(8):763-8. PubMed ID: 3938558
    [No Abstract]   [Full Text] [Related]  

  • 4. Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders.
    Kobrinsky NL; Israels ED; Gerrard JM; Cheang MS; Watson CM; Bishop AJ; Schroeder ML
    Lancet; 1984 May; 1(8387):1145-8. PubMed ID: 6144876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hermansky-Pudlak syndrome: correction of bleeding time by 1-desamino-8D-arginine vasopressin.
    Wijermans PW; van Dorp DB
    Am J Hematol; 1989 Mar; 30(3):154-7. PubMed ID: 2916560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shortening of bleeding time after intranasal administration of 1-deamino-8-D-arginine vasopressin to patients with chronic uremia.
    Rydzewski A; Rowiński M; Myśliwiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):823-30. PubMed ID: 2436997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous desmopressin (DDAVP) shortens the bleeding time in uremia.
    Viganò GL; Mannucci PM; Lattuada A; Harris A; Remuzzi G
    Am J Hematol; 1989 May; 31(1):32-5. PubMed ID: 2705441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DDAVP in uremia.
    Vicente V; Alberca I; Macias JF; Lopez Borrasca A
    Nephron; 1984; 36(2):145-6. PubMed ID: 6420716
    [No Abstract]   [Full Text] [Related]  

  • 9. Intranasal deamino-8-D-arginine vasopressin shortens the bleeding time in uremia.
    Shapiro MD; Kelleher SP
    Am J Nephrol; 1984; 4(4):260-1. PubMed ID: 6332534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 1-deamino-8-D-arginine vasopressin on the prolonged bleeding time in chronic renal failure.
    Watson AJ; Keogh JA
    Nephron; 1982; 32(1):49-52. PubMed ID: 6817151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on mechanisms of a haemostatic effect of 1 deamino-8-D-arginine vasopressin (desmopressin) in uraemic patients.
    Malyszko J; Pietraszek M; Buczko W; Mysliwiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(2):319-24. PubMed ID: 1697836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of desmopressin (DDAVP) on protein C and protein C inhibitors in uremia.
    Akpolat T; Ozdemir O; Arik N; Demirkan F; Sungur C; Ozcebe O; Dündar S; Yasavul U; Turgan C; Kirazli S
    Nephron; 1993; 64(2):232-4. PubMed ID: 8321356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uremic plasma after infusion of desmopressin (DDAVP) improves the interaction of normal platelets with vessel subendothelium.
    Escolar G; Cases A; Monteagudo J; Garrido M; Lopez J; Ordinas A; Revert L; Castillo R
    J Lab Clin Med; 1989 Jul; 114(1):36-42. PubMed ID: 2738447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desmopressin-induced improvement of abnormal coagulation in chronic liver disease.
    Agnelli G; Berrettini M; De Cunto M; Nenci GG
    Lancet; 1983 Mar; 1(8325):645. PubMed ID: 6131320
    [No Abstract]   [Full Text] [Related]  

  • 15. DDAVP releases tPA in correlation with a fall in platelet serotonin in uraemic patients.
    Malyszko J; Malyszko JS; Azzadin A; Mysliwiec M; Buczko W
    Thromb Res; 1992 Nov; 68(3):303-8. PubMed ID: 1471076
    [No Abstract]   [Full Text] [Related]  

  • 16. Desmopressin control of surgical hemorrhage secondary to prolonged bleeding time.
    Sieber PR; Belis JA; Jarowenko MV; Rohner TJ
    J Urol; 1988 May; 139(5):1066-7. PubMed ID: 3361648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Possible role of serotonin in hemostatic the mechanism of action of desmopressin (DDAVP) in patients with uremia].
    Małyszko J; Małyszko J; Pietraszek M; Azzadin A; Myśliwiec M; Buczko W
    Pol Arch Med Wewn; 1993 Aug; 90(2):105-11. PubMed ID: 8247943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correction of bleeding time after administration of desmopressin in a woman treated with ticlopidine].
    Calenda E; Papion H; Borg JY; Menguy E; Delaunay T; Watelet J; Testart J; Winckler C
    Presse Med; 1988 Nov; 17(40):2143. PubMed ID: 2974154
    [No Abstract]   [Full Text] [Related]  

  • 19. Discrepancy in fibrinolytic response to desmopressin as compared to venous occlusion--a preliminary report.
    Nilsen DW; Andersen P; Hjermann I; Godal HC
    Thromb Haemost; 1985 Feb; 53(1):160. PubMed ID: 3992517
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on kidney function in subjects exposed to organic solvents. II. The effect of desmopressin in a concentration test and the effect of exposure to organic solvents on renal concentrating ability.
    Askergren A; Allgën LG; Bergström J
    Acta Med Scand; 1981; 209(6):485-8. PubMed ID: 7257866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.